Search Orphan Drug Designations and Approvals
-
Generic Name: | brentuximab vedotin |
---|---|
Date Designated: | 11/13/2018 |
Orphan Designation: | Treatment of extranodal NK/T-cell lymphoma (ENKTL) |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 02/25/2019 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Seattle Genetics, Inc. 21823 30th Drive Southeast Bothell, Washington 98021 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-